triple-hormone-receptor agonist retatrutide for obesity

triple-hormone-receptor agonist retatrutide for obesity ⭐️topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Retatrutide - Triple GLP-1R /

Name: triple-hormone-receptor agonist retatrutide for obesity ⭐️topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Retatrutide - Triple GLP-1R /
Brand: pharmaregulatorysummit.com
SKU: 98452685787
Price: 24.21 USD
Availability: InStock
Rating: 4.3042 (23 reviews)

SKU: 98452685787

4.3

EUR24.21 EUR51.21

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Steel, C., Guinea, A., McCarthy, J

AKR1C3 promoted EMT by regulating transcription factors and signaling pathways and led tumor cells to acquire more aggressive and metastatic characteristics of mesenchymal cells (Thiery et al., 2009)